Puma Biotechnology Inc (NASDAQ:PBYI)

67.10
Delayed Data
As of Feb 21
 +0.05 / +0.07%
Today’s Change
28.35
Today|||52-Week Range
136.90
-32.12%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues0.000.000.006.1M
 
 
Cost of Goods Sold0.000.000.00626.0K
 
 
Depreciation And Amortization584.0K277.0K274.0K900.0K
 
 
 
 
 
 
Operating ExpensesGross Income-584.0K-277.0K-274.0K4.6M
 
 
 
 
 
General Expenses72.3M72.9M77.9M82.0M
 
 
 
 
 
Research And Development56.4M54.8M53.3M49.5M
 
 
 
 
 
Total Operating Expenses72.9M73.2M78.2M83.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-72.9M-73.2M-78.2M-77.4M
 
 
 
 
 
Other Expenses-100.0K-13.0K-30.0K-45.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-72.7M-72.9M-77.8M-77.2M
 
 
 
 
 
Net Income-72.7M-72.9M-77.8M-77.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS35.7M36.9M37.0M37.2M
 
 
 
 
 
Shares To Calculate EPS Diluted35.7M36.9M37.0M37.2M
 
 
 
 
 
 
Earnings Per ShareEPS-$2.04-$1.97-$2.10-$2.07
 
 
 
 
 
EPS Diluted-$2.04-$1.97-$2.10-$2.07